Polaris Group (TPE:6550)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
13.40
+0.30 (2.29%)
Jun 5, 2026, 1:30 PM CST
Market Cap11.26B -66.0%
Revenue (ttm)69.27M -21.0%
Net Income-3.82B
EPS-4.81
Shares Out 859.89M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,987,072
Open13.20
Previous Close13.10
Day's Range13.05 - 13.65
52-Week Range12.80 - 44.55
Beta0.61
Analystsn/a
Price Targetn/a
Earnings DateAug 28, 2026

About Polaris Group

Polaris Group, together with its subsidiaries, offers biotechnology, pharmaceutical testing, and contract development and manufacturing services. The company engages in the research, development, manufacture and sale of new drugs. It also offers healthcare consulting, staffing, and MDS solutions. The company was incorporated in 2006 and is based in Grand Cayman, Cayman Islands. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2006
Employees 165
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 6550
Full Company Profile

Financial Performance

In 2025, Polaris Group's revenue was 40.60 million, a decrease of -62.05% compared to the previous year's 107.00 million. Losses were -3.93 billion, 56.9% more than in 2024.

Financial Statements